EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sopharma AD-Sofia's Enterprise Value is лв1,155 Mil.
Sopharma AD-Sofia's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was лв2 Mil. Therefore, Sopharma AD-Sofia's EV-to-FCF for today is 661.99.
The historical rank and industry rank for Sopharma AD-Sofia's EV-to-FCF or its related term are showing as below:
XBUL:SFA'
s EV-to-FCF Range Over the Past 10 Years
Min: -47.27 Med: -4.87 Max: 1092.66
Current: 661.99
During the past 13 years, the highest EV-to-FCF of Sopharma AD-Sofia was 1092.66. The lowest was -47.27. And the median was -4.87.
XBUL:SFA's EV-to-FCF is ranked worse than 96.77% of 62
companies
in the Medical Distribution industry
Industry Median: 22.77
vs XBUL:SFA: 661.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Sopharma AD-Sofia's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sopharma AD-Sofia's EV-to-FCF
For the Medical Distribution subindustry, Sopharma AD-Sofia's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia's EV-to-FCF Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's EV-to-FCF falls into.
Sopharma AD-Sofia's current Enterprise Value is лв1,155 Mil.
Sopharma AD-Sofia's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sopharma AD-Sofia's PE Ratio for today is calculated as:
Sopharma AD-Sofia's share price for today is лв6.02.
Sopharma AD-Sofia's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sopharma AD-Sofia EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Sopharma AD-Sofia's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBUL:SFA has been successfully added to your 